This article has been updated with information from Roche's earnings presentation.

NEW YORK (GenomeWeb) – Roche today reported that its 2016 diagnostics revenues grew 6 percent year over year, driven by strong immunodiagnostics product sales within its centralized and point-of-care solutions business.

The company reported CHF 50.58 billion ($51.09 billion) in 2016 revenues, up 5 percent from CHF 48.15 billion in 2015. At constant exchange rates, the firm's revenues grew 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.